NRXP NRX Pharmaceuticals shares climb 352 percent as investors shrug off worse than expected Q4 2025 EPS miss SLB SLB Q1 2026 Earnings Analysis Middle East Headwinds Offset HighGrowth Digital and Production Segments Invest IGACR Stock Is It Gaining Traction Materials Select Sector SPDR Fund XLB Positioned for Upside Amid Citis Defensive Global Equity Strategy Overhaul AAUC Allied Gold posts narrow Q4 2025 EPS beat shares dip 139 amid tepid investor sentiment BLDP Ballard posts narrower than expected Q4 2025 loss even as shares dip slightly in todays trading ASX ASE Tech posts 148 percent Q4 2025 EPS beat but shares fall 389 percent in todays trading Hewlett HPE Market Conditions Q1 2026 Profit Surprises